Skip to main content

Together we are beating cancer

Donate now

Analysis

Showing 12 out of 2540 results
A packet of Viagra pills

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

by Jacob Smith | Analysis | 21 June 2022

21 June 2022

Cancer Research UK researchers

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

by Jacob Smith | Analysis | 16 June 2022

16 June 2022

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges
Dame Deborah James

Since she was diagnosed in 2016, Dame Deborah James has brought bowel cancer into the spotlight, encouraged people to be aware of the symptoms and seek help if they notice them.  Since she was diagnosed in 2016, Dame Deborah James has brought bowel cancer into the spotlight, encouraged people to be aware of the symptoms and seek help if they notice them. 

by Jacob Smith | Analysis | 24 May 2022

24 May 2022

Patrick McGuire, one of our Campaigns Ambassadors, with his partner Sue

To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government's upcoming 10-year Cancer Plan. To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government's upcoming 10-year Cancer Plan.

by Jacob Smith | Analysis | 6 May 2022

6 May 2022

Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons

by Phil Prime | Analysis | 3 May 2022

3 May 2022

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

by Lilly Matson | Analysis | 27 April 2022

27 April 2022

Researchers at work in a Cancer Research UK laboratory

You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons. You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.

by Lilly Matson | Analysis | 26 April 2022

26 April 2022

Medical technologist holding urine tube test in medical laboratory

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

by Lilly Matson | Analysis | 16 April 2022

16 April 2022

Doctors in a hospital corridor

A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival. A new study from the ICBP has reported international differences in proportions of cancer emergency presentations, and links this to differences in cancer survival.

by Jacob Smith | Analysis | 7 April 2022

7 April 2022